Literature DB >> 15057562

Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results.

Nicholas Gourtsoyiannis1, Nickolas Papanikolaou, John Grammatikakis, George Papamastorakis, Panos Prassopoulos, Maria Roussomoustakaki.   

Abstract

Every single imaging finding that can be disclosed on conventional and MR enteroclysis was correlated with the Crohn's disease activity index (CDAI). Nineteen consecutive patients with Crohn's disease underwent colon endoscopy and both conventional and MR enteroclysis examinations. Seventeen MR imaging findings and seven conventional enteroclysis findings were ranked on a four-point grading scale and correlated with CDAI, with a value of 150 considered as the threshold for disease activity. Six patients had active disease in the colon according to colon endoscopy. In the remaining 13 patients, the presence of deep ulcers ( P=0.002), small bowel wall thickening ( P=0.022) and gadolinium enhancement of mesenteric lymph nodes ( P=0.014) identified on MR enteroclysis images were strongly correlated to disease activity. The product of deep ulcers and enhancement of lymph node ranks identified on MR enteroclysis were the optimum combination for discriminating active from non-active disease ( F-test: 55.95, P<0.001). Additionally, the ranking of deep ulcers on conventional enteroclysis provided statistically significant differences between active and non-active patients ( F-test: 14.12, P=0.004). Abnormalities strongly suggestive of active Crohn's disease can be disclosed on MR enteroclysis examinations and may provide pictorial information for local inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057562     DOI: 10.1007/s00330-004-2302-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  MR enteroclysis: technical considerations and clinical applications.

Authors:  Nicholas Gourtsoyiannis; Nickolas Papanikolaou; John Grammatikakis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2002-06-04       Impact factor: 5.315

2.  Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings.

Authors:  H W Umschaden; D Szolar; J Gasser; M Umschaden; H Haselbach
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

Review 3.  Fibrofatty proliferation of the mesentery in Crohn disease.

Authors:  H Herlinger; E E Furth; S E Rubesin
Journal:  Abdom Imaging       Date:  1998 Jul-Aug

4.  Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery.

Authors:  S M Madsen; H S Thomsen; P Munkholm; B Davidsen; S Dorph; S Levin Nielsen; P Schlichting
Journal:  Scand J Gastroenterol       Date:  2002-03       Impact factor: 2.423

5.  MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution.

Authors:  N Gourtsoyiannis; N Papanikolaou; J Grammatikakis; T Maris; P Prassopoulos
Journal:  Invest Radiol       Date:  2000-12       Impact factor: 6.016

Review 6.  MR enteroclysis imaging of Crohn disease.

Authors:  P Prassopoulos; N Papanikolaou; J Grammatikakis; M Rousomoustakaki; T Maris; N Gourtsoyiannis
Journal:  Radiographics       Date:  2001-10       Impact factor: 5.333

7.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

8.  Crohn's disease of the small intestine: a review of the radiological appearances in 100 consecutive patients examined by a barium infusion technique.

Authors:  D J Nolan; N C Gourtsoyiannis
Journal:  Clin Radiol       Date:  1980-09       Impact factor: 2.350

9.  Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation.

Authors:  U Kettritz; K Isaacs; D M Warshauer; R C Semelka
Journal:  J Clin Gastroenterol       Date:  1995-10       Impact factor: 3.062

10.  Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Authors:  B R Yacyshyn; W Y Chey; J Goff; B Salzberg; R Baerg; A L Buchman; J Tami; R Yu; E Gibiansky; W R Shanahan
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more
  28 in total

1.  Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study.

Authors:  Burcu Narin; Waleed Ajaj; Susanne Göhde; Jost Langhorst; Haldun Akgöz; Guido Gerken; Stefan G Rühm; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2004-06-18       Impact factor: 5.315

Review 2.  Small bowel imaging-- a rapidly changing field and a challenge to radiology.

Authors:  Dean D T Maglinte
Journal:  Eur Radiol       Date:  2006-01-05       Impact factor: 5.315

3.  Assessment of Crohn's disease in the small bowel: Prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis.

Authors:  Gabriele Masselli; Emanuele Casciani; Elisabetta Polettini; Silvia Lanciotti; Luca Bertini; Gianfranco Gualdi
Journal:  Eur Radiol       Date:  2006-06-24       Impact factor: 5.315

4.  A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis.

Authors:  Anne Negaard; Vemund Paulsen; Leiv Sandvik; Audun Elnaes Berstad; Arne Borthne; Kirsti Try; Idar Lygren; Tryggve Storaas; Nils-Einar Klow
Journal:  Eur Radiol       Date:  2007-05-05       Impact factor: 5.315

Review 5.  Magnetic resonance imaging in Crohn's disease.

Authors:  Rakesh Sinha; Chuka Nwokolo; Paul D Murphy
Journal:  BMJ       Date:  2008-02-02

6.  Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy.

Authors:  Johannes Sailer; Philipp Peloschek; Walter Reinisch; Harald Vogelsang; Karl Turetschek; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-05-27       Impact factor: 5.315

7.  CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants.

Authors:  Giuseppe Lo Re; Maria Cappello; Chiara Tudisca; Massimo Galia; Claudia Randazzo; Antonio Craxì; Calogero Cammà; Andrea Giovagnoni; Massimo Midiri
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

8.  Conventional ultrasound and contrast-enhanced ultrasound in evaluating the severity of Crohn's disease.

Authors:  Chang Liu; Xiao-Rong Xu; Hui-Xiong Xu; Zhan-Ju Liu; Yi-Feng Zhang; Li-Ping Sun; Jun-Mei Xu; Lin-Na Liu; Le-Hang Guo; Xiao-Wan Bo
Journal:  Int J Clin Exp Med       Date:  2015-01-15

9.  Small bowel MRI enteroclysis or follow through: which is optimal?

Authors:  Ian C Lawrance; Christopher J Welman; Peter Shipman; Kevin Murray
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

10.  Assessment of activity of Crohn's disease of the ileum and large bowel: proposal for a new multiparameter MR enterography score.

Authors:  L Macarini; L P Stoppino; A Centola; S Muscarella; F Fortunato; F Coppolino; N Della Valle; V Ierardi; P Milillo; R Vinci
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.